The Brain Resource Center has been in close collaboration with Brain Resource Ltd. (www.brainresource.com), an International consortium of researchers, who have established a standardized benchmark in databasing the human brain through unprecedented levels of integration and quality control. Brain Resource Ltd. contributes data via BRAINnet to many research studies.
ARE YOU CURRETLY BEING TREATED FOR A RELAPSING FORM OF MULTIPLE SCLEROSIS?
A research study is currently being conducted
to learn about patients' satisfaction and safety
of fingolimod compared to other MS drugs.
You may qualify to participate in this study if you:
• are between the ages of 18 and 65
• have been diagnosed with a relapsing form of MS
• have taken a drug used to control your MS
symptoms for 6 months or longer
Please contact the Brain Resource Center at: 212-877-0424
Address:
263 West End Ave. #1D
New York, NY 10023
• Between 18-65 years old.
• Diagnosed with LUPUS.
• Suffering from PAIN more than 2 times a week.
You could qualify for a clinical trial with a medication to help relieve Lupus pain. Qualified participants receive all study-related
care and study drug at no cost and may be compensated for time and travel.
Please contact the Brain Resource Center at: Call: 787-505-9989 or 212-877-0424
General office number will not work for this purpose
ADHD STUDY: PARTICIPANTS NEEDED – CHILDREN 6 – 17 YEARS OLD
For research related inquiries you need to contact :
Call: 646-216-8977
General office number will not work for this purpose
Our facility is conveniently located for both New York and New Jersey volunteers in Englewood Cliffs, NJ and easily accessible by public transit, just across from the George Washington Bridge.
The Depression study is closed. We no longer need participants for this study.
Feeling depressed or have been diagnosed with depression?
The aim of this study is to identify brain, cognitive and genetic markers that predict treatment response to 3 antidepressant medications.
This study is for male or female individuals who are:
18-65 years of age
Diagnosed with major depressive disorder and no recent use of antidepressant medication
Whose primary language is English
You will be required to satisfy study criteria and attend a medical screening and clinical assessment before being permitted to participate in the study.
While your brain activity is being measured via non-invasive brain-mapping methods, you will be asked to perform various tasks (e.g. focused attention, memory recall, etc.). You will also be asked to provide a blood sample, and answer questions about your medical history.
The study will involve two 5-6 hour testing sessions and additional 30 minute phone and internet follow-up sessions.
You will be compensated for your time and any costs incurred in participating in this study.
The memory study is closed. We no longer need participants for this study.
Adult participants needed for an at-home study. The aim of the study is to examine memory and cognition in adults ages 50-65.
The study is for males or females:
50-65 years of age
Primary language is English
Willing and able to commit to the time and task requirements of the study (up to 30 minutes a day, 5 days a week for
6 weeks from your home)
Have the vision, hearing, motor, and comprehension skills to successfully complete assessment and required tasks
Have a computer (PC only) at home with a fast Internet connection
You are not eligible for participation in this study if you:
Are currently living with severe depression or anxiety
Participated in another cognitive/ memory related study within last 3 months
Have a history of head trauma with loss of consciousness or stroke that led to cognitive impairment
Are diagnosed with Alzheimer’s disease or a seizure disorder
Are planning to begin, or changing dosing of, cholinesterase inhibitors
You will be required to satisfy study criteria before being permitted to participate in the study. Participants may be asked to:
Complete online cognitive assessments
